A comprehensive view of u.s. food and drug administration (fda). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AbbVie reports FDA has requested further information on subcutaneous pump used in its ABBV-951 combination therapy to treat Parkinson’s disease; treatment uses foscarbidopa and foslevodopa along with pump device
Published: March 23, 2023 by FiercePharma
FDA advisor committee supports conditional clearance of Biogen’s tofersen ALS drug; tofersen treats ALS caused by SOD1 gene mutation, which is estimated to be responsible for less than 500 of the approximately 30,000 ALS cases in the US
Published: March 23, 2023 by BioPharma Dive
Ascend Labs recalls 10 lots of dabigatran etexilate anticoagulant capsules in US after routine test finds suspected carcinogen N-nitroso-dabigatran; products shipped between June 2022 and October 2022
Published: March 23, 2023 by FiercePharma
China approves its first mRNA vaccine, a domestic shot made by CSPC Pharmaceutical reports Bloomberg; FDA may make decision on new round of booster shots for people 65 years old and older in coming weeks reports WSJ
Published: March 22, 2023 by FiercePharma
Private-label OTC provider Granules Consumer Health completes audit by US FDA with zero 483 observations at its packaging facility in Manassas, Virginia; facility is spread over 79,000 sq. ft. and has several packaging suites to service customer needs
Published: March 22, 2023 by Dion Global Solutions Limited

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count